To analyze Pten and Smad4 gene expression in the urogenital system of Wistar rats in differents ages.
Introduction
Cancer is the second most common cause of death worldwide. Annually, more than 12.7 million people are diagnosed with cancer and 7.6 million die of this condition. Between 1975 and 2000, the incidence of cancer doubled, and the incidence of cancer is expected to double again by 2020 and triple by 2030, when the cancer death rate is predicted to reach 17 million per year. Lung, breast, and colon cancers are the most commonly diagnosed cancers worldwide 1 .
Multiple genes are related to the control of cellular proliferation and prevention of tumorigenesis. The Pten (phosphatase tensin homologue) gene encodes a protein phosphatase that functions as a tumor suppressor and is involved in various physiological processes, including cell proliferation, migration, survival, and apoptosis. Pten is a key regulator of a signaling pathway that controls cell division, mediates apoptosis, and prevents excessive cell growth 2 . Since its discovery in 1997, Pten has been established as one of the most commonly mutated tumor suppressors in human cancer; deficiency of Pten enzymatic activity has been implicated in the development of gliomas and breast, endometrial, lung, and prostate cancers 3 . The PTEN gene has been shown to be mutated in 40-50% of gliomas and in up to 70% of prostate cancers 4 . Smad4 belongs to a family of transcription factors that mediate the transforming growth factor (TGF)-beta signaling associated with cell proliferation and differentiation, angiogenesis, and extracellular matrix remodeling 5 . A recent study has shown that Pten and Smad4 together with Spp1 and cyclin D1 form a four-gene signature that is prognostic for recurrence and lethal metastasis in human prostate cancer. The Gleason grading scale has an accuracy of 60-70% in determining prostate cancer aggressiveness, whereas the prognostic accuracy of the four gene-based analyses reaches 83%. The combination of the four biomarkers and the Gleason score has a predictive accuracy of approximately 90% and can be applied to determine the aggressiveness of prostate cancer 6 . The expression of the Pten and Smad4 genes has been extensively investigated. However, only a few studies have reported the expression of these genes in the urogenital system. In this study, we evaluated the expression of the Pten and Smad4 genes in the urogenital organs of Wistar rats at different ages.
Methods
The study was approved by the Ethics Committee for the care and use of experimental animals of the State University of Rio de Janeiro (CEUA021/2012) and followed the principles set out in The Guide for the Care and Use of Laboratory Animals.
Wistar rats from the colony of the Urogenital Research Unit were kept in polypropylene boxes in a temperature-controlled (21°C ± 2°C) 12-h light-dark cycle (07:00 h-19:00 h) environment and received food and water ad libitum. The animals were divided into four age groups: pre-pubertal (21 days; 10 male and 5 female rats); pubertal (50 days; 10 male and 5 female rats); young adult (90 days; 10 male and 5 female rats) and middle-aged (180 days; 10 male and 9 female rats).
Puberty was determined on the basis of the vaginal opening in female rats and the separation of the foreskin in male rats. The animals were euthanized by intraperitoneal injection of sodium pentobarbital (30 mg/kg) and the bladder, testis, prostate, uterus, and ovaries were removed, fixed in liquid nitrogen, and stored at -80°C until analysis by real-time PCR (qPCR).
Real-time PCR
RNA was extracted from the tissues using Trizol 
Statistical analysis
The data were tested for normality and homogeneity of the variance and have been presented as the mean ± standard deviation (SD). Differences among the groups were established by one-way analysis of variance (one-way ANOVA) followed by Bonferroni's post hoc test; p £ 0.05 was considered statistically significant. All analyses were performed using Prism version 5.00
for Windows (GraphPad Software, San Diego, CA, USA).
Results
Pten mRNA expression in the bladder of middle-aged male rats was increased by 95%, 91%, and 80% relative to animals from the pre-pubertal, pubertal, and young adult groups, respectively ( Table 2 ). Pten mRNA levels were also significantly elevated by 95%, 96%, and 90% in the prostate of the oldest age group relative to that of the pre-pubertal, pubertal, and young adult groups, respectively (Table 2 ). In the testes, Pten mRNA expression increased by 45% in young adults relative to pre-pubertal animals, whereas the middleaged male rats showed a 66% reduction in Pten mRNA levels relative to the young adult group (Table 2) . Pten mRNA levels in the bladder were similar in female and male rats. The middle-aged group showed an increase of 83%, 82%, and 85% in Pten mRNA levels compared with the pre-pubertal, pubertal, and young adult groups, respectively (Table 2) . Pten mRNA levels in the ovaries were increased by 78% in middle-aged rats relative to young adult rats (Table 2) . However, no statistically significant difference was observed in uterine Pten mRNA expression among the age groups (Table 2 ).
Smad4 expression in the bladder of middle-aged male rats was elevated by 78% compared to that in pubertal animals (Table 2) . Similarly, in the prostate of the oldest age group, Smad4 mRNA levels increased by 74%, 51%, and 76% compared to those in the pre-pubertal, pubertal, and young adult groups, respectively (Table 2 ). However, in the testes, the highest Smad4 mRNA expression was observed for the youngest, prepubertal rats, whereas reductions of 93%, 83%, and 95% were detected for the pubertal, young adult, and middle-aged rats, respectively ( Table 2) . Bladder Smad4 mRNA levels in middleaged females were higher than those in the pre-pubertal (77%), pubertal (75%), and young adult (75%) groups (Table 2 ). In the ovaries of the pubertal animals, Smad4 expression was reduced by 72% compared to that in the pre-pubertal group; however, the middle-aged group showed an 82% increase in Smad4 mRNA levels relative to the pubertal animals ( Table 2 ).
In the uterus, Smad4 expression in the oldest group was 94%, 82%, and 88% higher than that in the pre-pubertal, pubertal, and young adult groups, respectively ( Table 2 ).
Data were reported as mean ± SD. The differences were tested by one-way analysis of variance (ANOVA) and the Bonferroni post hoc test, p <0.05.
[ 6 . In a murine model of prostate cancer, Pten activity is also closely associated with the production of follicle-stimulating hormone (FSH). Acute stimulation of rat testicular Sertoli cells, required for male sexual development, by FSH has been found to increase Pten synthesis and enzymatic activity, thus identifying a new, Pten-dependent mechanism of regulating spermatogenesis 11 . In rats, FSH plasma levels peak between 10 and 15 weeks and decline after this period 12 , which agrees with our findings that, in rat testes, Pten expression increased with maturation from the pre-pubertal (21 days) to the young adult (90 days) stage, but then decreased in the older, middle-aged (180 days) group.
In the ovaries, Pten mRNA levels were higher in middleaged rats than in young adults, thus presenting a pattern opposite to that of estrogen production, which is maximal in the proestrus stage (80-100 days) 13 and declines after 180 days 14 . In this study,
we detected an increase in Smad4 mRNA levels in the prostate of the middle-aged rats, which may indicate a protective mechanism against cancer development in the aging prostate. In the female gonads, Smad4 gene expression was higher in pre-pubertal animals than in pubertal animals, suggesting involvement in the early phases of folliculogenesis and ovarian development 22, 23 . However, in contrast to male rats, middle-aged female rats demonstrated an increase in Smad4 mRNA expression in the reproductive organs (ovaries and uterus) relative to the pubertal and young adult groups. Given the role of Smad4 as a tumor suppressor 24 , these changes may be indicative of the Smad4 related anti-proliferative mechanisms induced in aging female rats as reproductive activity declines 25 .
Conclusion
The Smad4 may be a part of the regulatory mechanism controlling the initial development of the rat reproductive system, whereas the elevated expression of both Pten and Smad4 mRNA in aging animals may indicate the activation of antiproliferative events required for the protection of the urogenital system against age-related carcinogenic stimuli.
